European Society For Paediatric Haematology And Immunology

The history of ESPHI goes back for 30 years when medical sciences in Europe started to recover from the aftermath of the Second World War and strived to develop a profile of their own. Originally a part of the European Society for Pediatric Research, it very soon developed into an independent society in its own right. Names of the most eminent pediatricians of their time are connected with the foundation of ESPHI. The ESPHI has, at present, 10 working groups where part of its scientific work is concentrated. These include groups in Diamond-Blackfan Anemia, Thrombosis and Hemostasis, Congenital and Acquired Hemolytic Anemias, Thrombocytopenias, Chronic Neutropenias, Neonatal Immunology, Myelodysplastic Syndromes, Developing Countries, Human Milk, and Fanconi's Anemia. Additional groups are in statu nascendi. Bi-annual workshops are held where the chairmen of all groups convene. 

The ESPHI meeting will bring together participants from many countries across Europe to discuss emerging science, share best practice and knowledge and to learn from experts and explore new tools and technologies.
A top-ranked faculty of invited speakers who are all well-known international experts in their field will participate by presenting and chairing sessions. Information will be shared on practice and research issues, standards of care, and educational opportunities. Networking and communication with other professional organisations are promoted.

ESPHI has its main scientific congress bi-annually, alternating with the workshops. The next congress will be in association with other eminent pediatric societies from Europe and the Americas. For the first time in its history ESPHI is venturing to hold a congress on American soil addressing in particular our colleagues in the Americas. 

The goals of ESPHI are to promote scientific research and its clinical application in pediatric hematology and immunology. Encompassing both hematology and immunology, with pseudopods into pediatric oncology, is the unique charm of the Society. ESPHI is presently expanding with new members in the United States, Canada, South Africa and developing countries. Engagement in developing countries not only opens up new fields of research but also is an expression of our sense of responsibility towards the underprivileged children living in these countries.